Interestingly, HMOX-1 expression also significantly stratified the patient outcome in BRAFV600E mutant melanoma samples (log-rank p = 0.03), as shown in Figure 2B (HR = 1.54, 95%CI = 1.05–2.27, p = 0.027). Here, HMOX1 is linked to melanoma.